You are currently logged into
POZ Directory - My Account or Log Out
POZ POZ
Logo

Treatment: Sunlenca Plus bnAbs

  • Share
  • Comment
  • Home
  • Basics
    • Basics
    • Introduction
    • HIV Transmission and Risks
    • HIV Testing
    • HIV Prevention
    • Newly Diagnosed
    • Starting HIV Treatment
    • HIV Medications
    • HIV Drug Assistance Programs
    • Other Related Conditions
    • VIH/SIDA en Español
  • News
    • News
    • Newsfeed
    • Science News
    • Features
    • Opinions
    • Conferences
    • Slideshows
    • Videos
    • POZ at Home
    • POZ TV
    • POZ Stories
    • POZ 100
    • By Author
    • RSS Links
  • Hot Topics
    • Hot Topics
    • POZ Awards
    • World AIDS Day
    • Criminalization
    • Cure
    • Long-Term Survivors
    • Newly Diagnosed
    • PrEP
    • Prevention
    • Undetectable (U=U)
    • Youth
  • Magazine
    • Magazine
    • Current Issue
    • Archives
    • Digital Editions
    • POZ Focus
    • POZ en Español
    • Subscriptions
    • Email Newsletters
  • Blogs
    • Blogs
    • Recent Posts
    • Browse Bloggers
    • RSS Links
  • Community
    • Community
    • POZ Personals
    • POZ Stories
    • POZ 100
    • Community
    • AIDS Is Everyday
    • Forums
    • Polls
    • Surveys
    • Quizzes
    • Ask POZ
    • Awareness Days
    • Services Directory
    • Calendar
    • Jobs
    • Bookstore
  • About Us
    • About Us
    • About Us
    • Masthead
    • Awards
    • Press Releases
    • Advertise
    • Contact Us

© 2026 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

© 2026 Smart + Strong.
All Rights Reserved.
Terms of use and
Your privacy.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.

Advertisement
  • Previous Prev Prevention: Implants and Inserts
  • MAIN MENU POZ June 2023
  • Next Cure: Stem Cell Cure
blue pages of a Calendar

Istock

Treatment: Sunlenca Plus bnAbs

A Phase II clinical trial will start this year to evaluate the potential twice-yearly regimen.

May 15, 2023 • By Liz Highleyman

Share


Bluesky
Email
Facebook
Pinterest
Tumblr
X (Twitter)
  • Share
  • Comments
  • Print

Advertisement

Sunlenca (lenacapavir), a new injectable HIV capsid inhibitor administered once every six months, has the potential to be paired with two broadly neutralizing antibodies (bnAbs) to construct a twice-yearly regimen. BnAbs are antibodies that bind to parts of the virus that don’t change very much as it evolves. Sunlenca is highly effective when combined with daily oral antiretrovirals, but so far it doesn’t have an equally durable partner for a complete long-acting regimen. In a small Phase Ib study, 21 people with an undetectable viral load stopped their existing oral antiretrovirals and received injections of Sunlenca plus infusions of two antibodies being developed by Gilead Sciences, dubbed teropavimab and zinlirvimab. Participants were tested in advance to ensure that their HIV was susceptible to both antibodies. Six months later, 90% maintained viral suppression. A Phase II clinical trial will start this year to evaluate whether viral suppression can be maintained when the regimen is administered every six months for a longer duration.


    Read More About:

  • #antiretrovirals
  • #Sunlenca
  • #viral suppression
Advertisement

Comments

Join The Discussion

Comments

  • Previous Prev Prevention: Implants and Inserts
  • MAIN MENU POZ June 2023
  • Next Cure: Stem Cell Cure

RELATED articles

Close Up Of Sleeping Baby Girl Lying On Parent's Bed At Home

HHS Updates Pediatric HIV Guidelines

Set of 3d up and down arrows in perspective. Green, pink arrows.

Immune Suppression Linked to HPV-Related Cancers

Monthly and yearly calendar. Paper calendar with date. Day planner. Weekly, monthly and yearly schedule. Modern organizer. Business diary. Deadline reminder. Daily events management.

Weekly HIV Treatment and PrEP Pills on the Horizon

Leronlimab (PRO 140)

Three-Prong Approach Might Clear HIV in Infants

Stay Logged In?

You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.

You Have Been Logged Out

Click here to log back in.

POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.